For receptor activation, yes all three engage GHRH receptors
This will also help the insurance companies in the long run since taking these anti-obesity medications will significantly improve the patient's overall health and lower the risk of complications caused by obesity
The rest, for most people, is an argument for continuing a treatment that works.
Are my digestive symptoms more consistent with inflammation, infection, IBS, food intolerance, medication effects, or another condition
CJC-1295 with DAC (Drug Affinity Complex) has an extended half-life of about 6-8 days, providing sustained GHRH receptor activation but potentially disrupting natural GH pulsatility
Your prescribing provider gives you the exact mL and unit markings for your specific vial and prescribed dose